Module

Risk Stratification and Management of High-Risk Patients

Source: Proceedings of the 17th International Prostate Cancer Update Meeting

Risk Stratification and Management of High-Risk Patients

Faculty:
Daniel P. Petrylak, MD

CME CREDIT INFORMATION

Release Date: 06/29/07

Expiration Date: 06/28/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss controversial issues in the management of high-risk patients
Summarize the use of radiation therapy and hormone therapy in the treatment of high-risk patients with prostate cancer
Review the use of prognostic factors, including novel diagnostic and prognostic techniques, in prostate cancer treatment

Topics covered include:

Introduction
Controversies in Managing High-Risk Patients
RT Plus HT for High-Risk Disease
Adjuvant Trials for Prostate Cancer
Can New Nomograms Better Predict Relapse Risk?
Prognostic Significance of PSA Nadir Following HT
Biochemical Failure: Lessons Learned
Role of Seminal Vesicle Biopsies and Other Procedures to Determine Optimal Management of Prostate Cancer

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.